Is the semiconductor correction an opportunity? The real core is… | Author Jang Woojin

Summary

The video is a live market commentary where author Jang Woojin discusses a sharp two-day correction in Korean semiconductors, driven by a Broadcom-led sell-off in US tech. He argues the semiconductor peak narrative is overblown and sees the dip as a buying opportunity. He recommends rotating into biotech and securities stocks, citing a strong US biotech rebound and a major buyback catalyst at Shinhan Securities. The discussion also covers FX risk, potential rate hikes, and sector rotation dynamics.

• Korean semiconductor stocks fell 4–5% following the Broadcom sell-off in the US.
• Jang Woojin disagrees that semiconductor earnings have peaked and views the drop as a buying opportunity.
• He expects a rotation into Korean biotech, noting a strong US biotech rebound and oversuppression of the local sector.
• Securities stocks are highlighted due to a large share buyback and cancellation at Shinhan Securities.
• FX rates above 1,440 won per dollar are flagged as a risk, potentially forcing a rate hike in July.
• Financial stocks (KB Financial, Shinhan Financial) show relative strength amid the broad sell-off.
• The overall market declined broadly, with only 239 stocks rising on KOSPI versus 618 falling.
• The host, whose name is not provided, shares a personal anecdote of heavy losses on Chinese stocks and an aversion to re-entering.